The 52-Week-Low List: 6 S&P 500 Names On Wednesday

SPY: State Street SPDR S&P 500 ETF Trust logo
SPY
State Street SPDR S&P 500 ETF Trust

A short list of market laggards includes some surprising names with rapidly growing businesses.

The weakness on Wednesday is scattered, with no single industry cluster among the 6 S&P 500 stocks at 52-week lows. The list includes giants like International Business Machines (IBM), with a market value of about $193.1 billion, which has declined 18.4% over the last month.

This is happening while the broader S&P 500 has returned +0.4% over the same period. The presence of companies with expanding sales raises a key question: when does a fast-growing business become a falling stock? The full list of names follows.

Photo by ArtsyBee on Pixabay

The Complete 52-Week-Low List

Relevant Articles
  1. A 6-Day Losing Streak Has Rubrik Stock Down 16%
  2. Same Industry, Less Money: What Boston Scientific and ResMed Offer That Abbott Laboratories Does Not
  3. Olin Stock Rides A 9-Day Winning Streak To A 20% Gain
  4. How Will NextEra Energy Stock React To Its Upcoming Earnings?
  5. A 9-Day Winning Streak Has NOV Stock Up 10%
  6. Canadian Natural Resources Stock Climbs 7.5% On A 6-Day Winning Streak

The table below lists every stock at its 52-week low, largest first, with one-day, one-week, one-month, and one-year returns:

Tickers Market
Cap
1D
% Chg
1W
% Chg
1M
% Chg
1Y
% Chg
IBM $193.1 Bil -2.2% -2.6% -18.4% -25.9%
MCD $187.3 Bil -0.1% -0.5% -2.4% -8.7%
ISRG $120.9 Bil -2.7% -12.4% -15.5% -34.0%
SNPS $72.3 Bil -2.9% -11.2% -18.7% -36.2%
CPRT $25.4 Bil 0.0% -0.4% -7.8% -41.0%
WYNN $9.7 Bil -0.3% -2.8% -8.9% -10.5%

Is a growth stock still a growth stock at a 52-week low?

Synopsys (SNPS) and Intuitive Surgical (ISRG) stand out for the disconnect between their business growth and stock performance. Synopsys posted revenue growth of 39.5% over the last twelve months, yet its stock suffered the steepest one-month slide on the list, down 18.7%. Similarly, Intuitive Surgical’s revenue grew 21.4%, while its stock has declined 15.5% over the last month. Both still trade at high multiples, with SNPS at 93.5 times trailing earnings and ISRG at 40.6 times.

A low price is a signal, not a verdict.

A list of stocks at their weakest price of the last year is a prompt for research, not a simple shopping list. A 52-week low can mark a permanently impaired business or a temporarily marked-down one. The disciplined move is to check the underlying fundamentals, like the 9.7% revenue growth at IBM or its 6.3% free cash flow yield, before the price chart can tell the full story.

If any of these names tempt you, resist buying a price alone. Our Buy the Dip screen asks the follow-up question that matters: which marked-down stocks still have the growth and cash generation to recover.

Weakness Is Information. It Is Not An Instruction

A 52-week low tells you what the market thinks today. It does not tell you what to do, and acting on price alone is how value traps get bought. The missing ingredient is always the same: is the business still sound?

Asking that question across thousands of stocks, every day, is exactly how the Trefis High Quality (HQ) Portfolio is built: roughly 30 names that pass the quality screens, held with rules instead of nerve. It has a track record of outpacing a benchmark that combines all major indices – the S&P 500, S&P Mid-cap, and Russell 2000. Let the low list sharpen your watchlist, and let the portfolio carry the risk.